305 related articles for article (PubMed ID: 33740049)
1. Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting With Continuous Glucose Monitoring: FUTURE-PEAK.
Broos B; Charleer S; Bolsens N; Moyson C; Mathieu C; Gillard P; De Block C
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3037-e3048. PubMed ID: 33740049
[TBL] [Abstract][Full Text] [Related]
2. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J
Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056
[No Abstract] [Full Text] [Related]
3. Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well-controlled youth with type 1 diabetes.
Charleer S; Gillard P; Vandoorne E; Cammaerts K; Mathieu C; Casteels K
Pediatr Diabetes; 2020 Dec; 21(8):1465-1474. PubMed ID: 32981187
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial.
Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
J Diabetes Sci Technol; 2024 May; 18(3):660-666. PubMed ID: 36172693
[TBL] [Abstract][Full Text] [Related]
5. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
[TBL] [Abstract][Full Text] [Related]
6. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
[TBL] [Abstract][Full Text] [Related]
7. Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study.
Charleer S; De Block C; Van Huffel L; Broos B; Fieuws S; Nobels F; Mathieu C; Gillard P
Diabetes Care; 2020 Feb; 43(2):389-397. PubMed ID: 31843948
[TBL] [Abstract][Full Text] [Related]
8. Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D).
Brown RE; Chu L; Norman GJ; Abitbol A
Diabet Med; 2022 Nov; 39(11):e14937. PubMed ID: 36065977
[TBL] [Abstract][Full Text] [Related]
9. Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Glycemic Control: A Randomized Controlled Trial.
Boucher SE; Gray AR; Wiltshire EJ; de Bock MI; Galland BC; Tomlinson PA; Rayns JA; MacKenzie KE; Chan H; Rose S; Wheeler BJ
Diabetes Care; 2020 Oct; 43(10):2388-2395. PubMed ID: 32788281
[TBL] [Abstract][Full Text] [Related]
10. Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study.
Leelarathna L; Sutton CJ; Evans ML; Neupane S; Rayman G; Lumley S; Cranston I; Narendran P; Krishan A; Taxiarchi VP; Barnard-Kelly K; Elliott RA; Burns M; Camm M; Thabit H; Wilmot EG;
Diabet Med; 2024 Mar; 41(3):e15249. PubMed ID: 37897112
[TBL] [Abstract][Full Text] [Related]
11. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
[TBL] [Abstract][Full Text] [Related]
12. Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial.
Jefferies CA; Boucsein A; Styles SE; Chamberlain B; Michaels VR; Crockett HR; De Lange M; Lala A; Cunningham V; Wiltshire EJ; Serlachius AS; Wheeler BJ
Diabetes Technol Ther; 2023 Dec; 25(12):827-835. PubMed ID: 37782139
[No Abstract] [Full Text] [Related]
13. Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.
Crabtree TSJ; Griffin TP; Yap YW; Narendran P; Gallen G; Furlong N; Cranston I; Chakera A; Philbey C; Karamat MA; Saraf S; Kamaruddin S; Gurnell E; Chapman A; Hussain S; Elliott J; Leelarathna L; Ryder REJ; Hammond P; Lumb A; Choudhary P; Wilmot EG;
Diabetes Care; 2023 Oct; 46(10):1831-1838. PubMed ID: 37566697
[TBL] [Abstract][Full Text] [Related]
14. Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.
Jensen MH; Cichosz SL; Gustenhoff P; Nikontovic A; Hejlesen O; Vestergaard P
PLoS One; 2022; 17(10):e0274626. PubMed ID: 36240184
[TBL] [Abstract][Full Text] [Related]
15. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
[TBL] [Abstract][Full Text] [Related]
16. Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes.
Yamada E; Nakajima Y; Horiguchi K; Okada S; Yamada M
Endocr J; 2023 Dec; 70(12):1187-1193. PubMed ID: 37766568
[TBL] [Abstract][Full Text] [Related]
17. Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial.
Yan J; Zhou Y; Zheng X; Zheng M; Lu J; Luo S; Yang D; Deng H; Xu W; Bi Y; Bao W; Weng J
Diabetes Metab Res Rev; 2023 May; 39(4):e3614. PubMed ID: 36670050
[TBL] [Abstract][Full Text] [Related]
18. Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study.
Petersson J; Åkesson K; Sundberg F; Särnblad S
Pediatr Diabetes; 2019 May; 20(3):339-344. PubMed ID: 30652407
[TBL] [Abstract][Full Text] [Related]
19. Personalizing the Use of a Intermittently Scanned Continuous Glucose Monitoring Device in Individuals With Type 1 Diabetes: A Cost-Effectiveness Perspective in the Netherlands (FLARE-NL 9).
Emamipour S; van Dijk PR; Bilo HJG; Edens MA; van der Galiën O; Postma MJ; Feenstra TL; van Boven JFM
J Diabetes Sci Technol; 2024 Jan; 18(1):135-142. PubMed ID: 35815617
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
